TISSIUM
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues, and deliver on-demand wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC, and CapDecisif Management.
TISSIUM
Industry:
Biotechnology Health Care Medical Device
Founded:
2013-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.tissium.com
Total Employee:
101+
Status:
Active
Contact:
+33 1 76 21 72 28
Email Addresses:
[email protected]
Total Funding:
210.04 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google Analytics Classic OVH DNS ScaleWay
Similar Organizations
Bolder Surgical
Bolder Surgical serves health care providers by developing surgical instruments that allow access to confined and delicate structures.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Current Employees Featured
Founder
Investors List
Fonds Stratégique d'Investissement
Fonds Stratégique d'Investissement investment in Series D - TISSIUM
Mérieux Equity Partners
Mérieux Equity Partners investment in Series D - TISSIUM
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Series D - TISSIUM
Cathay Health
Cathay Health investment in Series D - TISSIUM
Sofinnova Partners
Sofinnova Partners investment in Series D - TISSIUM
Sofinnova Partners
Sofinnova Partners investment in Series C - TISSIUM
Cathay Capital
Cathay Capital investment in Series C - TISSIUM
CM-CIC Capital Prive
CM-CIC Capital Prive investment in Debt Financing - TISSIUM
BNP Paribas
BNP Paribas investment in Debt Financing - TISSIUM
Bpifrance
Bpifrance investment in Debt Financing - TISSIUM
Key Employee Changes
| Date | New article |
|---|---|
| 2023-01-17 | TISSIUM Appoints Alex Milstein as Chief Medical Officer |
| 2022-01-10 | TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy |
| 2021-07-01 | TISSIUM Appoints Romain Attard as Chief Financial Officer |
Official Site Inspections
http://www.tissium.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.22 K
- Host name: pro.faciliweb.fr
- IP address: 193.70.73.133
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "TISSIUM"
The Story and Team Behind Biomorphic Programmable Polymers
Thierry Darnis leads the Global Operations at Tissium, (Development & industrialization, Quality, Chemical Characterization and Manufacturing). He has a deep background of more than 30 …See details»
Org Chart Tissium - The Official Board
Organizational Chart of Tissium. Tissium tissium.com. has 14 executives +33 1 7621 7228; Add an executive. Tissium News . Anything missing? We search for you. Print or download . Board. N-1. N-2 . CEO & Director. Christophe Bancel. …See details»
TISSIUM - Crunchbase Company Profile & Funding
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the …See details»
Tissium Company Profile | Management and Employees List
Tissium Profile and History. TISSIUM is a privately-owned medtech company that is dedicated to the rapid development and commercialization of a unique biopolymer platform to address …See details»
TISSIUM Overview | SignalHire Company Profile
TISSIUM is a private company that has been in the industry for 11 years. The company currently specializes in the Medical Devices, Health Care Technology areas. ... Organization Website: …See details»
TISSIUM Company Profile 2024: Valuation, Funding
When was TISSIUM founded? TISSIUM was founded in 2013. Where is TISSIUM headquartered? TISSIUM is headquartered in Paris, France. What is the size of TISSIUM? TISSIUM has 100 total employees. What industry is TISSIUM in? …See details»
Tissium
TISSIUM is a privately-owned medical technology company with headquarters in Paris and Boston. We also have an Industrial Site located in Roncq. We specialise in the development and commercialization of a unique biopolymer …See details»
TISSIUM Company Profile - Office Locations, Competitors ... - Craft
TISSIUM has 5 employees across 3 locations and $81.84 m in total funding,. See insights on TISSIUM including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
TISSIUM Raises €50M in Series D Funding to finance its …
May 23, 2023 Paris, France, Boston, USA, May 23, 2023 – TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series D round …See details»
TISSIUM - Funding, Financials, Valuation & Investors - Crunchbase
TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery. Search Crunchbase. Start Free Trial . ... How much funding has …See details»
TISSIUM - Contacts, Employees, Board Members, Advisors & Alumni
Organization. TISSIUM . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of Board …See details»
HR Department - Tissium
Founded in 2013, Tissium is a fast-moving medical device company dedicated to developing innovative tissue reconstruction solutions. We leverage our technology platforms to develop …See details»
TISSIUM Closes €39M Series B Funding Round - TISSIUM
TISSIUM, a privately-owned life science company developing fully synthetic, biomorphic programmable polymers, announced today it has raised €38.75 million ($42.78 million) in a …See details»
Cathay Health Increases its Stake in TISSIUM with €50M Series D
May 23, 2023 About Tissium. TISSIUM, a privately-owned MedTech company based in Paris, France and Boston, USA, is dedicated to the development and commercialization of products …See details»
TISSIUM Company Profile - Office Locations, Competitors ... - Craft
TISSIUM (formerly known as Gecko Biomedical) is a life science company developing fully synthetic, biomorphic programmable polymers. These polymers are designed to be used …See details»
Tissium Company Information - Funding, Investors, and More
Tissium, based in Paris, shows significant growth potential in the healthcare sector with its innovative biodegradable sealants and adhesives for wound closure. Unlike traditional …See details»
Behind the Term Sheet: How TISSIUM is creating the future of …
Sep 1, 2021 TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series C round …See details»
Alon Natanson Appointed as Chief Executive Officer of Yissum, …
2 days ago The CEO of AFHU will join the organization at a pivotal moment in time, succeeding a successful leader and building on a legacy of tremendous growth. In partnership with …See details»
TISSIUM Raises €50M in Series C Financing to Propel its Platform …
Paris, France, August 31, 2021 – TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a …See details»
US SIF Announces Election of New Board Members and Board Chair
21 hours ago WASHINGTON, D.C., January 08, 2025 - US SIF: The Sustainable Investment Forum announced today the election of a new Board Chair and eight Directors for the 2025 …See details»